Chemiluminescence Immunoassay Analyzers Market, Analysis By Key Players, SWOT Analysis, Growth Factors and Forecast till 2027

 

Chemiluminescence Immunoassay Analyzers Market

Chemiluminescence Immunoassay Analyzers Market Research Report

Market Overview

During the projection period from 2021 to 2028, the global Chemiluminescence Immunoassay Analyzers Market is expected to increase at a CAGR of 3.5 percent, from USD 10.85 billion in 2021 to USD XX billion in 2028. The two primary reasons driving this market's rise are the increased need for automated chemiluminescence immunoassays and the rising number of clinical trials in emerging nations.

Chemiluminescence An immunoassay analyzer detects the amount of antigen or antibody present in serum, blood, or urine samples. It detects and quantifies antigens or antibodies using light from excited molecules. Because no specific training is required, the tests are quick and simple to complete. The chemiluminescence immunoassay analyzer's technique is based on the idea of luminescence. Fluorescent compounds, such as acridinium esters and luciferins, are used as the light source in this approach. These devices emit Short-wave ultraviolet (UV) light. The Chemiluminescence Immunoassay Analyzer is precise, dependable, and quick. It can detect single target molecules in a very short time, even at very low concentrations. An enzyme-linked assay can also be performed using the chemiluminescent reaction and radioimmunoassay (RIA).

Major key players

There are many prominent key players present in the market. Among all the key players investing in the market, here is the list of most prominent ones-

  • Abbott
  • Hoffmann-La Roche Ltd
  • Siemens Healthcare GmbH (Siemens AG)
  • Danaher (Beckman Coulter, Inc.)
  • DiaSorin S.p.A.
  • Ortho Clinical Diagnostics (Part of Carlyle Group)
  • Shenzhen New Industries Biomedical Engineering Co., Ltd.
  • Sysmex Corporation
  • Randox Laboratories Ltd.
  • Tosoh Corporation
  • Others

Market Segmentation

By Type

The Chemiluminescence Immunoassay (CLIA) Analyzers Market is further divided based on type into:

●        Medium Throughput

●        High Throughput

●        Low Throughput

By Product

The Chemiluminescence Immunoassay (CLIA) Analyzers Market is further divided based on type into:

●        Reagents

●        Luminophore Markers

●        Enzymatic Markers

●        Analyzer

●        Semi-automated

●        Consumables

●        Automated

By Application

The Chemiluminescence Immunoassay (CLIA) Analyzers Market is further divided based on type into:

●        Oncology & Endocrinology

●        Cardiac Markers

●        Hepatitis and Retroviruses

●        Infectious Disease

●        Auto-Immune Diseases

●        Bone and Mineral Disorders

●        Allergy

●        Drug Discovery and Development

●        GI Stool Testing

●        Others

By End-User

The Chemiluminescence Immunoassay (CLIA) Analyzers Market is further divided based on type into:

●        Hospitals & Clinics

●        Pharmaceutical & Biotechnology Industries

●        Medical & Diagnostic Laboratories

●        Others

Regional Classification

The market is divided into five regions: North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa. North America is expected to dominate the market during the projected period, with the highest CAGR. During the projection period, Latin America is anticipated to witness the fastest market for chemiluminescence immunoassay analyzers. The second-largest market share is expected to be held by Europe. Asia Pacific is predicted to be the second-fastest-growing market for chemiluminescence immunoassay analyzers during the projection period. Chemiluminescence immunoassay analyzers have the smallest market in the Middle East and Africa.

Industry News

The number of tests that use Chemiluminescence Immunoassay Analyzers (CLIA) techniques is expected to grow due to technological advancements in illness detection and increased demand for preventive diagnosis and treatment monitoring.

As a result, demand for high-throughput systems is increasing. Furthermore, by adopting CLIA approaches, large-scale laboratories capture a larger portion of the market by exploiting the quality and service limits experienced by small and mid-volume laboratories.

International corporations in the clinical labs' category increase their footprint in new areas through acquisitions and mergers. As laboratories consolidate, test volumes increase, resulting in a rise in comprehensive laboratory automation and integration adoption.

The rising occurrence of chronic diseases like cancer is due to rapid dietary habits and lifestyle changes. As a result, the rising prevalence of acute and chronic disorders is propelling the market.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Comments

Post a Comment

Popular posts from this blog

Dry Age-Related Macular Degeneration Market Size, Share, Application Analysis, Regional Outlook, Growth Trends, Competitive Strategies

Image
  Dry Age-Related Macular Degeneration Market This degenerative eye disease is caused by the thinning of the macula and interferes with a clear vision in the elderly. The macula is part of the retina that facilitates clear vision; when this part of the eye deteriorates, it causes blurred or distorted vision. But this does not mean that the individual will lose his or her sight, only the central vision is affected by this degenerative disease, and the peripheral vision remains intact. Vision loss is slow and can be corrected using innovative ocular treatments. It has been estimated that the Dry Age-Related Macular Degeneration Market has seen a jump due to increased research in drugs, rising amount of COVID-19 cases among the old and age-restricted chronic diseases.   The dry age-related macular degeneration AMD market is expected to cross USD 15,351.07 million by 2027 at a CAGR of 8.20% during the forecast period   List of Key Companies Covered...
Read more

Cardiopulmonary Resuscitation Market: Innovations and Trends Shaping Life-Saving Techniques

  Introduction Cardiopulmonary Resuscitation (CPR) stands as a vital life-saving technique that has transformed emergency healthcare. As the cornerstone of effective response to cardiac arrest, the CPR market has been witnessing remarkable advancements driven by technology, research, and innovation. This article delves into the evolving landscape of the Cardiopulmonary Resuscitation Market, highlighting its trends, innovations, and impact on global healthcare. CPR: A Lifeline in Critical Moments Cardiopulmonary resuscitation, commonly referred to as CPR, is a crucial technique employed to sustain blood circulation and provide oxygen to the brain during cardiac arrest. It involves chest compressions and, in some cases, rescue breaths to maintain oxygen levels until professional medical assistance arrives. CPR significantly increases the chances of survival when performed promptly and correctly. Market Growth and Trends The CPR market has been experiencing steady growth due to incre...
Read more

Pain Management Devices Market Set To Exhibit Strong Growth, Valuable Research Factors and Industry Forecast to 2030

Image
  Pain Management Devices Market – Overview The Pain Management Devices Market can anticipate expansion at a rate of 7.12% from 2020 to 2030, believes MRFR (Market Research Future). Progress in technology and better research capabilities have led to the development of devices that can control pain with limited use of drugs. Focused Market reports connected to the healthcare sector among others lately have been made available by Market Research Future which publishes a report on this sector. The development of pain management devices has been useful to control pain in a wide range of ailments. The level of relief from pain that is experienced, is one of the major driving factors for the industry, as patients who use such devices are prone to chronic pain daily. Cancer patients and the geriatric population are among the major user segments for the pain management devices as medication alone may not be sufficient to provide pain relief in their situation. The industry is antici...
Read more